Evidence-Based Use of Rehabilitation Strategies Following Stroke
Alexander Dromerick, M.D. -- Associate Professor of Neurology and Occupational Therapy
Washington University School of Medicine -- Presented September 21, 2004


Click here to begin


References

Feeney DM, Gonzalez A, Law WA.
Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury.
Science. 1982 Aug 27;217(4562):855-7.

Stroemer RP, Kent TA, Hulsebosch CE.
Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats.
Stroke. 1998 Nov;29(11):2381-93.

Dhillon HS, Carbary T, Dose J, Dempsey RJ, Prasad MR.
Activation of phosphatidylinositol bisphosphate signal transduction pathway after experimental brain injury: a lipid study.
Brain Res. 1995 Nov 6;698(1-2):100-6.

Hurwitz BE, Dietrich WD, McCabe PM, Alonso O, Watson BD, Ginsberg MD, Schneiderman N.
Amphetamine promotes recovery from sensory-motor integration deficit after thrombotic infarction of the primary somatosensory rat cortex.
Stroke. 1991 May;22(5):648-54.

Crisostomo EA, Duncan PW, Propst M, Dawson DV, Davis JN.
Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients.
Ann Neurol. 1988 Jan;23(1):94-7.

Reding MJ
Neurology 1992; 42 (suppl 3): 329

Walker-Batson D, Smith P, Curtis S, Unwin H, Greenlee R.
Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence.
Stroke. 1995 Dec;26(12):2254-9.

Sonde L, Nordstrom M, Nilsson CG, Lokk J, Viitanen M.
A double-blind placebo-controlled study of the effects of amphetamine and physiotherapy after stroke.
Cerebrovasc Dis. 2001;12(3):253-7.

Grade C, Redford B, Chrostowski J, Toussaint L, Blackwell B.
Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study.
Arch Phys Med Rehabil. 1998 Sep;79(9):1047-50.

Scheidtmann K, Fries W, Muller F, Koenig E.
Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study.
Lancet. 2001 Sep 8;358(9284):787-90.

van der Lee JH, Wagenaar RC, Lankhorst GJ, Vogelaar TW, Deville WL, Bouter LM.
Forced use of the upper extremity in chronic stroke patients: results from a single-blind randomized clinical trial.
Stroke. 1999 Nov;30(11):2369-75.

Dromerick AW, Edwards DF, Hahn M.
Does the application of constraint-induced movement therapy during acute rehabilitation reduce arm impairment after ischemic stroke?
Stroke. 2000 Dec;31(12):2984-8.

Gelber DA, Good DC, Dromerick A, Sergay S, Richardson M.
Open-label dose-titration safety and efficacy study of tizanidine hydrochloride in the treatment of spasticity associated with chronic stroke.
Stroke. 2001 Aug;32(8):1841-6.

Simpson DM, Alexander DN, O'Brien CF, Tagliati M, Aswad AS, Leon JM, Gibson J, Mordaunt JM, Monaghan EP.
Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.
Neurology. 1996 May;46(5):1306-10.

Lagalla G, Danni M, Reiter F, Ceravolo MG, Provinciali L.
Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb.
Am J Phys Med Rehabil. 2000 Jul-Aug;79(4):377-84.

Bakheit AM, Thilmann AF, Ward AB, Poewe W, Wissel J, Muller J, Benecke R, Collin C, Muller F, Ward CD, Neumann C.
A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.
Stroke. 2000 Oct;31(10):2402-6.

Childers MK, Brashear A, Jozefczyk P, Reding M, Alexander D, Good D, Walcott JM, Jenkins SW, Turkel C, Molloy PT.
Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke.
Arch Phys Med Rehabil. 2004 Jul;85(7):1063-9.

Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C; Botox Post-Stroke Spasticity Study Group.
Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
N Engl J Med. 2002 Aug 8;347(6):395-400.

Pittock SJ, Moore AP, Hardiman O, Ehler E, Kovac M, Bojakowski J, Al Khawaja I, Brozman M, Kanovsky P, Skorometz A, Slawek J, Reichel G, Stenner A, Timerbaeva S, Stelmasiak Z, Zifko UA, Bhakta B, Coxon E.
A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.
Cerebrovasc Dis. 2003;15(4):289-300.

Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN.
Intrathecal baclofen for spastic hypertonia from stroke.
Stroke. 2001 Sep;32(9):2099-109.

Francisco GE, Boake C.
Improvement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: a preliminary study.
Arch Phys Med Rehabil. 2003 Aug;84(8):1194-9.

 

Internet Stroke Center at Washington University:
Copyright © 1997 -2007 All rights reserved.